IMR Press / CEOG / Volume 28 / Issue 3 / pii/2001040

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Editorial

Maternal/paternal sharing of DQ-Alpha type II histocompatibility antigens not associated with pregnancy outcome following in vitro fertilization (IVF)-embryo transfer (ET)

Show Less
1 Cooper Medical School of Rowan University, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology & Infertility, Camden, NJ (USA)
Clin. Exp. Obstet. Gynecol. 2001, 28(3), 142–143;
Published: 10 September 2001
Abstract

Purpose: To determine if maternal/paternal sharing of DQ alpha major histocompatibity (MHC) type II antigens is associated with reduced pregnancy and implantation rates following in vitro fertilization-embryo transfer (IVF-ET). Methods: Prospective study with type II MHC DQ alpha alleles detected by polymerase chain reaction (PCR) technology using Perkin Elmer Amyli-type HLA DQ alpha PCR amplification and typing kit. The tests were only performed on patients having their first IVF cycle. Results: No difference was found in clinical pregnancy rates per transfer between those couples sharing DQ alpha 1 alleles and those who did not (43.7% vs 40%). There were no spontaneous abortions in the group sharing DQ alpha 1 alleles. Conclusion: Maternal/paternal sharing of DQ alpha I antigens does not reduce fecundity following IVF-ET.

Keywords
IVF-ET
Major histocompatibility antigens
Fecundity
Sharing
Share
Back to top